Cargando…
A Fragment of Apolipoprotein E4 Leads to the Downregulation of a CXorf56 Homologue, a Novel ER-Associated Protein, and Activation of BV2 Microglial Cells
Despite the fact that harboring the apolipoprotein E4 (APOE4) allele represents the single greatest risk factor for late-onset Alzheimer's disease (AD), the exact mechanism by which apoE4 contributes to disease progression remains unknown. Recently, we demonstrated that a 151 amino-terminal fra...
Autores principales: | Pollock, Tanner B., Mack, Jacob M., Day, Ryan J., Isho, Noail F., Brown, Raquel J., Oxford, Alexandra E., Morrison, Brad E., Hayden, Eric J., Rohn, Troy T. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Hindawi
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6526552/ https://www.ncbi.nlm.nih.gov/pubmed/31198491 http://dx.doi.org/10.1155/2019/5123565 |
Ejemplares similares
-
Transcriptome Analyses in BV2 Microglial Cells Following Treatment With Amino-Terminal Fragments of Apolipoprotein E
por: Pollock, Tanner B., et al.
Publicado: (2020) -
The Potential of CRISPR/Cas9 Gene Editing as a Treatment Strategy for Alzheimer’s Disease
por: Rohn, Troy T, et al.
Publicado: (2018) -
Novel clinical and genetic insight into CXorf56-associated intellectual disability
por: Rocha, Maria Eugenia, et al.
Publicado: (2019) -
Inhibition of CXorf56 promotes PARP inhibitor-induced cytotoxicity in triple-negative breast cancer
por: Zhu, Ying, et al.
Publicado: (2023) -
Apolipoprotein E Fragmentation within Lewy Bodies of the Human Parkinson’s Disease Brain
por: Rohn, Troy T, et al.
Publicado: (2018)